Novartis drug shown to ease symptoms of painful skin condition
Novartis said its anti-inflammatory drug Cosentyx eased the symptoms of a painful, lump-forming skin condition… Read More
2 years ago
Novartis
GSK, Novartis pledge funds for diseases that mostly affect the poor
GSK and Novartis on Thursday reinforced commitments to address neglected tropical diseases, as world leaders… Read More
2 years ago
‘No profit’ COVID-19 drugs promised to low-income countries
Novartis’s Sandoz division will not make a profit on 15 generic drugs it is making… Read More
4 years ago
Novartis to provide ‘no profit’ COVID-19 drugs to low-income countries
Hydroxychloroquine, is not included after some COVID-19 trials concluded it did not work Read More
4 years ago
Charity to pay $4 million to resolve pharma kickback probe
A charity will pay $4 million to resolve claims that it acted as a conduit… Read More
5 years ago
Medicare to cover expensive cancer cell therapies
The US Centers for Medicare and Medicaid Services (CMS) on Wednesday said it has finalized… Read More
5 years ago
Second death in gene therapy trials under investigation
Novartis AG says investigation is underway into whether a second trial death could be related… Read More
5 years ago
Novartis, Pfizer join forces on potentially lucrative fatty liver disease
ZURICH/NEW YORK: Novartis and Pfizer are teaming up to develop treatments for a liver disease… Read More
6 years ago
Novartis hopeful for novel heart drug, despite ‘modest’ benefit
ZURICH: Novartis will seek regulatory approval this year for a new kind of anti-inflammatory heart… Read More
7 years ago
Trump pushes drugmakers for lower prices, more U.S. production
WASHINGTON/LOS ANGELES: U.S. President Donald Trump on Tuesday met with top executives from some of the… Read More
8 years ago
Novartis says 82 percent of leukemia patients in remission after CAR-T
BASEL, Switzerland: An experimental cancer therapy being developed by Novartis AG eliminated an aggressive form… Read More
8 years ago
Novartis backs off from 2016 date for testing Google autofocus lens
NEW YORK: Novartis has abandoned a 2016 goal to start testing its autofocus contact lens… Read More
8 years ago
Asthma pill hailed in early test for people with severe symptoms
PARIS: The first new asthma pill in nearly 20 years has led to a sharp improvement… Read More
8 years ago
FDA knocks back Novartis copy of Amgen’s drug Neulasta
WASHINGTON: U.S. regulators have declined to approve Novartis' so-called biosimilar copy of Amgen's Neulasta drug… Read More
8 years ago
Novartis study shows skin cancer combo also works on lungs
CHICAGO: A Novartis trial of two drugs against an aggressive lung cancer bodes well for… Read More
8 years ago
Facing rival drugs, Novartis gets win with Afinitor in Europe
LONDON: Efforts by Novartis to defend its blockbuster cancer drug Afinitor against competitors got a… Read More
8 years ago
Turkish prosecutor opens investigation into Novartis: media
The Ankara Chief Prosecutor has launched an investigation into the Turkish unit of Swiss drugmaker… Read More
9 years ago
FDA approves Novartis's drug for painful skin disease
The U.S. Food and Drug Administration approved Novartis AG's injectable drug, Cosentyx, to treat adults… Read More
10 years ago